These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 33317389)

  • 1. COVID-19 vaccines and treatments nationalism: Challenges for low-income countries and the attainment of the SDGs.
    Nhamo G; Chikodzi D; Kunene HP; Mashula N
    Glob Public Health; 2021 Mar; 16(3):319-339. PubMed ID: 33317389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility.
    Eccleston-Turner M; Upton H
    Milbank Q; 2021 Jun; 99(2):426-449. PubMed ID: 33650737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opportunities to accelerate immunization progress in middle-income countries.
    Zhu J; Cole CB; Fihman J; Adjagba A; Dasic M; Cernuschi T
    Vaccine; 2024 Apr; 42 Suppl 1():S98-S106. PubMed ID: 37460357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risky business: COVAX and the financialization of global vaccine equity.
    Stein F
    Global Health; 2021 Sep; 17(1):112. PubMed ID: 34544439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 vaccines for low- and middle-income countries.
    Choi EM
    Trans R Soc Trop Med Hyg; 2021 May; 115(5):447-456. PubMed ID: 33733663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Causes and costs of global COVID-19 vaccine inequity.
    Ferranna M
    Semin Immunopathol; 2024 Jan; 45(4-6):469-480. PubMed ID: 37870569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancing sustainable development goals through immunization: a literature review.
    Decouttere C; De Boeck K; Vandaele N
    Global Health; 2021 Aug; 17(1):95. PubMed ID: 34446050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustainable financing for Immunization Agenda 2030.
    Saxenian H; Alkenbrack S; Freitas Attaran M; Barcarolo J; Brenzel L; Brooks A; Ekeman E; Griffiths UK; Rozario S; Vande Maele N; Ranson MK
    Vaccine; 2024 Apr; 42 Suppl 1():S73-S81. PubMed ID: 36464542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The quest for more effective vaccine markets - Opportunities, challenges, and what has changed with the SARS-CoV-2 pandemic.
    Cernuschi T; Malvolti S; Hall S; Debruyne L; Bak Pedersen H; Rees H; Cooke E
    Vaccine; 2024 Apr; 42 Suppl 1(Suppl 1):S64-S72. PubMed ID: 38103962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which roads lead to access? A global landscape of six COVID-19 vaccine innovation models.
    Alonso Ruiz A; Bezruki A; Shinabargar E; Large K; Vieira M; Slovenski I; Liu Y; Agarwal S; Becker A; Moon S
    Global Health; 2024 Mar; 20(1):25. PubMed ID: 38532484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine nationalism is not unethical from a political ethics perspective: Learning from the global COVID-19 vaccine distribution failure.
    Shao Q
    Health Policy; 2024 Mar; 141():104996. PubMed ID: 38266331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Out of Africa: A Solidarity-Based Approach to Vaccine Allocation.
    Jecker N; Atuire C
    Hastings Cent Rep; 2021 May; 51(3):27-36. PubMed ID: 33939182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring income-associated inequalities in COVID-19 vaccination on a global scale: a modeling study.
    Amimo F; Magit A
    J Public Health Policy; 2023 Sep; 44(3):449-463. PubMed ID: 37604927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 vaccine inequity in African low-income countries.
    Kunyenje CA; Chirwa GC; Mboma SM; Ng'ambi W; Mnjowe E; Nkhoma D; Ngwira LG; Chawani MS; Chilima B; Mitambo C; Crampin A; Mfutso-Bengo J
    Front Public Health; 2023; 11():1087662. PubMed ID: 36950103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical analysis of COVAX alliance and corresponding global health governance and policy issues: a scoping review.
    Pushkaran A; Chattu VK; Narayanan P
    BMJ Glob Health; 2023 Oct; 8(10):. PubMed ID: 37793808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment.
    Wouters OJ; Shadlen KC; Salcher-Konrad M; Pollard AJ; Larson HJ; Teerawattananon Y; Jit M
    Lancet; 2021 Mar; 397(10278):1023-1034. PubMed ID: 33587887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-COVID-19 health inequalities: Estimates of the potential loss in the evolution of the health-related SDGs indicators.
    Silveira F; Miranda W; Sousa RP
    PLoS One; 2024; 19(7):e0305955. PubMed ID: 39046943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profits First, Health Second: The Pharmaceutical Industry and the Global South Comment on "More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry's Role in Widening the Access Gap".
    Lexchin J
    Int J Health Policy Manag; 2024; 13():8471. PubMed ID: 39099498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethical and Practical Considerations for an Agreement to Ensure Equitable Vaccine Access Comment on "More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry's Role in Widening the Access Gap".
    Ortiz-Millán G
    Int J Health Policy Manag; 2024; 13():8516. PubMed ID: 39099496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global inequity creates local insufficiency: A qualitative study of COVID-19 vaccine implementation challenges in low-and-middle-income countries.
    Haldane V; Ariyarajah A; Berry I; Loutet M; Salamanca-Buentello F; Upshur REG
    PLoS One; 2023; 18(2):e0281358. PubMed ID: 36780502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.